Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Other Operating Expenses (2018 - 2025)

Historic Other Operating Expenses for Organogenesis Holdings (ORGO) over the last 3 years, with Q3 2025 value amounting to $37.2 million.

  • Organogenesis Holdings' Other Operating Expenses rose 3872.59% to $37.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.6 million, marking a year-over-year decrease of 11468.87%. This contributed to the annual value of $22.8 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Organogenesis Holdings reported Other Operating Expenses of $37.2 million as of Q3 2025, which was up 3872.59% from $29.4 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Other Operating Expenses registered a high of $52.0 million during Q2 2024, and its lowest value of -$84.7 million during Q4 2024.